OxyContin maker pleads guilty to misleading public on drug addictiveness

[JURIST] Drug maker Purdue Pharma LP [corporate website] pleaded guilty Thursday and agreed to pay $634.5 million [plea agreement, PDF] in fines for misleading the public about the addiction risk of a painkiller it produced. According to prosecutors, Purdue knew in 1995 that doctors were worried that the drug OxyContin [FDA materials] was addictive, but hid that information from its sales representatives. In a statement [PDF text], the company admitted that some employees had made inaccurate statements about OxyContin to physicians.

Earlier this week, Purdue agreed to pay $19.5 million [AP report] to 26 states and the District of Columbia to settle charges that it pushed doctors to overprescribe OxyContin. AP has more.

 

About Paper Chase

Paper Chase is JURIST's real-time legal news service, powered by a team of 30 law student reporters and editors led by law professor Bernard Hibbitts at the University of Pittsburgh School of Law. As an educational service, Paper Chase is dedicated to presenting important legal news and materials rapidly, objectively and intelligibly in an accessible format.

© Copyright JURIST Legal News and Research Services, Inc., 2013.